Even though the global consumer health market remains highly fragmented two of the largest players say they don’t expect to strike any transformational deals any time soon.
Transformational M&A Not On Horizon For Haleon Or Bayer
Haleon CEO Brian McNamara and Bayer Consumer Health president Julio Triana independently tell the Barclays Consumer Conference that their respective firms are unlikely to secure any transformational mergers or acquisitions in the medium term. Both companies are prioritizing bolt-on acquisitions for the next few years.
More from Strategy
• By
CRN/Radicle Science expand Trailblazer Award nominations; BodyArmor brand relaunch with ‘Choose Better’ campaign and pro athletes; and Just Ingredients catches Bryce Harper as partner.
• By
Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.
• By
Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.
• By
A round-up of the latest European health & wellness market moves: Maxwellia names chief operating officer; Nestle appoints marketing & sales head; Alland & Robert gets deputy general manager.